Your browser doesn't support javascript.
loading
Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study.
Mahlich, Jörg; Olbrich, Kerstin; Wilk, Adrian; Wimmer, Antonie; Wolff-Menzler, Claus.
Afiliação
  • Mahlich J; Health Economics and Outcomes Research, Janssen, Pharmaceutical Companies of Johnson & Johnson, Neuss, Germany. joerg.mahlich@gmail.com.
  • Olbrich K; Düsseldorf Institute of Competition Economics (DICE), University of Düsseldorf, Düsseldorf, Germany. joerg.mahlich@gmail.com.
  • Wilk A; Health Economics and Outcomes Research, Janssen, Pharmaceutical Companies of Johnson & Johnson, Neuss, Germany.
  • Wimmer A; Team Gesundheit, Gesellschaft für Gesundheitsmanagement mbH, Essen, Germany.
  • Wolff-Menzler C; Medical Affairs, Janssen, Pharmaceutical Companies of Johnson & Johnson, Neuss, Germany.
Clin Drug Investig ; 40(4): 355-375, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32152867
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Hospitalização Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Hospitalização Idioma: En Ano de publicação: 2020 Tipo de documento: Article